Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
Authors:
Open Access
- 2 February 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 20253
Abstract
Melanoma is a highly malignant neoplasm of melanocytes with considerable metastatic potential and drug resistance, explaining the need for new candidates that inhibit tumor growth and metastasis. The signal transducer and activator of the transcription 3 (Stat3) signaling pathway plays an important role in melanoma and has been validated as promising anticancer target for melanoma therapy. In this study, nifuroxazide, an antidiarrheal agent identified as an inhibitor of Stat3, was evaluated for its anti-melanoma activity in vitro and in vivo. It had potent anti-proliferative activity against various melanoma cell lines and could induce G2/M phase arrest and cell apoptosis. Moreover, nifuroxazide markedly impaired melanoma cell migration and invasion by down-regulating phosphorylated-Src, phosphorylated-FAK and expression of matrix metalloproteinase (MMP) -2, MMP-9 and vimentin. It also significantly inhibited tumor growth without obvious side effects in the A375-bearing mice model by inducing apoptosis and reducing cell proliferation and metastasis. Notably, nifuroxazide significantly inhibited pulmonary metastases, which might be associated with the decrease of myeloid-derived suppressor cells (MDSCs). These findings suggested that nifuroxazide might be a potential agent for inhibiting the growth and metastasis of melanoma.Keywords
This publication has 42 references indexed in Scilit:
- The Omega-3 Polyunsaturated Fatty Acid DHA Induces Simultaneous Apoptosis and Autophagy via Mitochondrial ROS-Mediated Akt-mTOR Signaling in Prostate Cancer Cells Expressing Mutant p53BioMed Research International, 2013
- Photooxidation of Amplex red to resorufin: Implications of exposing the Amplex red assay to lightFree Radical Biology and Medicine, 2012
- A Landscape of Driver Mutations in MelanomaCell, 2012
- Both miR-17-5p and miR-20a Alleviate Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating STAT3 ExpressionThe Journal of Immunology, 2011
- The Role of Mitochondria in ApoptosisAnnual Review of Genetics, 2009
- Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3Blood, 2008
- A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T CellsClinical Cancer Research, 2008
- Targeting STAT3 affects melanoma on multiple frontsCancer and Metastasis Reviews, 2005
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002